# Humana Announces Agreement to Divest Minority Interest in Gentiva
Canonical URL: https://biopharmsignal.com/news/HUM/humana-announces-agreement-to-divest-minority-interest-in-gentiva
Ticker: HUM
Company: Humana
Source: Humana
Published: 2026-06-25 13:46 EST
Original Source URL: https://humana.gcs-web.com
## Summary

LOUISVILLE, Ky. --(BUSINESS WIRE)--Jun. 10, 2026-- Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading provider of end-of-life services,

## Article Body
LOUISVILLE, Ky. --(BUSINESS WIRE)--Jun. 10, 2026-- Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading provider of end-of-life services,
## Recent Company News
- 2026-06-25 13:46 EST — [Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026](https://biopharmsignal.com/news/HUM/humana-inc-to-release-second-quarter-2026-results-on-july-29-2026) — Source: Humana
- 2026-06-25 13:46 EST — [Humana Announces Agreement to Divest Minority Interest in Gentiva](https://biopharmsignal.com/news/HUM/humana-announces-agreement-to-divest-minority-interest-in-gentiva) — Source: Humana
- 2026-06-25 13:46 EST — [Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026](https://biopharmsignal.com/news/HUM/humana-inc-to-release-fourth-quarter-2025-results-on-february-11-2026) — Source: Humana
- 2026-06-25 13:46 EST — [Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance](https://biopharmsignal.com/news/HUM/humana-reports-fourth-quarter-2025-financial-results-provides-full-year-2026-financial-guidance) — Source: Humana
- 2026-06-25 13:46 EST — [Humana Inc. to Present at the 2026 Leerink Partners Global Healthcare Conference](https://biopharmsignal.com/news/HUM/humana-inc-to-present-at-the-2026-leerink-partners-global-healthcare-conference) — Source: Humana
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)